Esanex

BioCrossroads Indiana Seed Fund II makes first investments in start-ups

Friday, January 11, 2013

BioCrossroads Indiana Seed Fund II, an $8.25 million early-stage fund focused on identifying, creating and developing the next generation of leading Indiana-based life sciences companies, has made its first two investments: Esanex, a company developing an oncology drug, and Algaeon, which has developed an algae cultivation technology for use in the nutraceutical and micronutrient markets. 

[Read More]